SILENCE THER. (SLN)

 

SLN Share PerformanceMore

52 week high135.00 21/04/16
52 week low95.00 24/01/17
52 week change -26.75 (-20.94%)
4 week volume1,660,377 24/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Silence update on stake in Arrowhead Pharmaceuticals

Silence Therapeutics has issued an update to its announcement on 9 January regarding the acquisition of a minority stake ...

Minority Stake in Arrowhead Pharmaceuticals

Miscellaneous medium priority announcements

Silence Therapeutics acquires minority stake in Arrowhead

Silence Therapeutics has acquired a stake, on-market, in Arrowhead Pharmaceuticals, Inc. of 6.01m shares, or 8.4% of the co...

Acquisition of Minority Stake in Arrowhead

Statement regarding an acquisition of a company or assets

Silence Therapeutics notes Quark arbitration resolution

Silence Therapeutics has reached a settlement in the arbitration process with Quark Pharmaceuticals. Silence and its license...

Silence announces Quark arbitration resolution

Statement regarding an alliance between entities

CRISPR/Cas9 Gene Editing Data

Miscellaneous medium priority announcements

Broker Forecast - Canaccord Genuity issues a broker note on Silence Therapeutics PLC

Canaccord Genuity today reaffirms its buy investment rating on Silence Therapeutics PLC (LON:SLN) and raised its price...

Fundamental DataMore

EPS-10.4
Dividend yield0 %

Latest discussion posts More

Users' HoldingsMore

Users who hold SILENCE THER. also hold..
LLOYDS GRP.27%
BP25%
BARCLAYS17%
TESCO17%
ROYAL BANK SCOT17%

Codes & Symbols

ISINGB00B9GTXM62
SymbolsSLN, LSE:SLN, SLN.L, SLN:LN, LON:SLN, XLON:SLN